Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
about
Modified Nucleoside Triphosphates for In-vitro Selection TechniquesExpected and unexpected features of protein-binding RNA aptamersP13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing.A synthetic molecular system capable of mirror-image genetic replication and transcription.Nanoparticle-Programmed Surface for Drug Release and Cell Regulation via Reversible Hybridization ReactionCrystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2.In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategiesBiostable L-DNAzyme for Sensing of Metal Ions in Biological Systems.Total chemical synthesis of a thermostable enzyme capable of polymerase chain reactionThrough-bond effects in the ternary complexes of thrombin sandwiched by two DNA aptamers.Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.Structural insight into proteolytic activation and regulation of the complement system.Mirror-image polymerase chain reaction.In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.Structural regulation by a G-quadruplex ligand increases binding abilities of G-quadruplex-forming aptamers.
P2860
Q26747256-126A4A0D-33DF-46E9-B02B-3B1A6790DB12Q26750235-11227532-55E0-436C-A722-7406661061AEQ30833038-D789A6E0-2391-420A-856E-1AC98B6736FBQ33363386-22D643EE-C030-43EE-B296-D5414B93C4C2Q33773285-6984BF19-2992-413F-8721-855DC72384FBQ35611323-AA031FBC-5253-4324-A9CA-35FF0EC2C5CCQ36156320-ADC44519-7664-4B2C-8ECA-A658303C448CQ36966466-47B0658E-07E9-436E-A9DD-3373E3B83926Q37678647-729FE97A-BA2B-4894-9AD3-B8EBCDB38142Q38289988-B5942DD1-1238-45CA-99C4-305A6622C000Q38291786-41A2D8C5-8B3B-4A77-AA77-2101FE93F64CQ38991069-32EBC581-CB7E-43FC-A8B5-2E58BF9E85DFQ42379129-F9B4E981-3753-4BAD-9F95-2BFE0B1D7042Q45742012-A0F18FA4-7E9E-41DA-A803-AEE60FDE7FD8Q47149355-3C13874E-6458-42F2-8538-862EA3CA135CQ51135569-9EF3892E-D89E-4EE9-9080-7654361670E3
P2860
Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Structural basis for the targe ...... g a mixed L-RNA/L-DNA aptamer.
@en
type
label
Structural basis for the targe ...... g a mixed L-RNA/L-DNA aptamer.
@en
prefLabel
Structural basis for the targe ...... g a mixed L-RNA/L-DNA aptamer.
@en
P2860
P50
P356
P1476
Structural basis for the targe ...... g a mixed L-RNA/L-DNA aptamer.
@en
P2093
Christian Maasch
Sven Klussmann
P2860
P2888
P356
10.1038/NCOMMS7481
P407
P577
2015-04-22T00:00:00Z
P5875
P6179
1000520484